Review



cd19 variants  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc cd19 variants
    Cd19 Variants, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 174 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19 variants/product/Cell Signaling Technology Inc
    Average 96 stars, based on 174 article reviews
    cd19 variants - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    99
    ATCC cd19 variants
    Anti-CD28 stimulation of <t>CD19-chimeric</t> antigen receptors (CAR) T cells is TMD dependent. (A) Designs of five CAR against CD19 bearing a 4-1BB costimulatory domain and differing by their hinge domain (HD) and their transmembrane domain (TMD). (B) Fluorescence-activated cell sorting (FACS) -sorted CD4 + CD127 + CD25 low T cells were electroporated with a CRISPR-Cas9 ribonucleoprotein complex (RNP) targeting the constant region of the TCR β chain gene (TRBC), followed by stimulation with anti-CD3/CD28 beads (1:1 ratio). (C) Representative results of flow cytometric analysis of the CD3 expression over time of cells electroporated with or without RNP. Percentages of residual CD3 + population and fold-expansion after 9 days of culture of CD4 + T cells electroporated with or without RNPs targeting TRBC are shown. Results from four independent experiments. (D) A representative example of carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution of a mixed population of CD3 +/− CAR +/− T restimulated with anti-CD3/28 beads. (E) The normalized CFSE mean fluorescence intensity (MFI) ratio for CD3 − mCherry + , CD3 + mCherry − , and CD3 + mCherry + cells was calculated by dividing CFSE MFI of these populations with the MFI of the CD3 − mCherry − cells in the same culture. Two-way ANOVA was used for statistical analysis (bold line set as reference). (F) Percentages of CD3 + and mCherry + cells before and 5 days after restimulation of edited T cells with anti-CD3/CD28 beads. The Unpaired t -test was performed by comparing CD8-TMD and CD28-TMD-containing CARs on D14. For (E,F) , the results shown are a summary of two independent experiments using T cells from five unrelated donors for each construct. *** p < 0.001.
    Cd19 Variants, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19 variants/product/ATCC
    Average 99 stars, based on 1 article reviews
    cd19 variants - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cd19 variants
    Anti-CD28 stimulation of <t>CD19-chimeric</t> antigen receptors (CAR) T cells is TMD dependent. (A) Designs of five CAR against CD19 bearing a 4-1BB costimulatory domain and differing by their hinge domain (HD) and their transmembrane domain (TMD). (B) Fluorescence-activated cell sorting (FACS) -sorted CD4 + CD127 + CD25 low T cells were electroporated with a CRISPR-Cas9 ribonucleoprotein complex (RNP) targeting the constant region of the TCR β chain gene (TRBC), followed by stimulation with anti-CD3/CD28 beads (1:1 ratio). (C) Representative results of flow cytometric analysis of the CD3 expression over time of cells electroporated with or without RNP. Percentages of residual CD3 + population and fold-expansion after 9 days of culture of CD4 + T cells electroporated with or without RNPs targeting TRBC are shown. Results from four independent experiments. (D) A representative example of carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution of a mixed population of CD3 +/− CAR +/− T restimulated with anti-CD3/28 beads. (E) The normalized CFSE mean fluorescence intensity (MFI) ratio for CD3 − mCherry + , CD3 + mCherry − , and CD3 + mCherry + cells was calculated by dividing CFSE MFI of these populations with the MFI of the CD3 − mCherry − cells in the same culture. Two-way ANOVA was used for statistical analysis (bold line set as reference). (F) Percentages of CD3 + and mCherry + cells before and 5 days after restimulation of edited T cells with anti-CD3/CD28 beads. The Unpaired t -test was performed by comparing CD8-TMD and CD28-TMD-containing CARs on D14. For (E,F) , the results shown are a summary of two independent experiments using T cells from five unrelated donors for each construct. *** p < 0.001.
    Cd19 Variants, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19 variants/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    cd19 variants - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    OriGene lentiviral particles containing transcript variant 1 of cd19 and gfp rc230267l4
    Anti-CD28 stimulation of <t>CD19-chimeric</t> antigen receptors (CAR) T cells is TMD dependent. (A) Designs of five CAR against CD19 bearing a 4-1BB costimulatory domain and differing by their hinge domain (HD) and their transmembrane domain (TMD). (B) Fluorescence-activated cell sorting (FACS) -sorted CD4 + CD127 + CD25 low T cells were electroporated with a CRISPR-Cas9 ribonucleoprotein complex (RNP) targeting the constant region of the TCR β chain gene (TRBC), followed by stimulation with anti-CD3/CD28 beads (1:1 ratio). (C) Representative results of flow cytometric analysis of the CD3 expression over time of cells electroporated with or without RNP. Percentages of residual CD3 + population and fold-expansion after 9 days of culture of CD4 + T cells electroporated with or without RNPs targeting TRBC are shown. Results from four independent experiments. (D) A representative example of carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution of a mixed population of CD3 +/− CAR +/− T restimulated with anti-CD3/28 beads. (E) The normalized CFSE mean fluorescence intensity (MFI) ratio for CD3 − mCherry + , CD3 + mCherry − , and CD3 + mCherry + cells was calculated by dividing CFSE MFI of these populations with the MFI of the CD3 − mCherry − cells in the same culture. Two-way ANOVA was used for statistical analysis (bold line set as reference). (F) Percentages of CD3 + and mCherry + cells before and 5 days after restimulation of edited T cells with anti-CD3/CD28 beads. The Unpaired t -test was performed by comparing CD8-TMD and CD28-TMD-containing CARs on D14. For (E,F) , the results shown are a summary of two independent experiments using T cells from five unrelated donors for each construct. *** p < 0.001.
    Lentiviral Particles Containing Transcript Variant 1 Of Cd19 And Gfp Rc230267l4, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lentiviral particles containing transcript variant 1 of cd19 and gfp rc230267l4/product/OriGene
    Average 90 stars, based on 1 article reviews
    lentiviral particles containing transcript variant 1 of cd19 and gfp rc230267l4 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc anti human cd19 antibody variant 9
    Anti-CD28 stimulation of <t>CD19-chimeric</t> antigen receptors (CAR) T cells is TMD dependent. (A) Designs of five CAR against CD19 bearing a 4-1BB costimulatory domain and differing by their hinge domain (HD) and their transmembrane domain (TMD). (B) Fluorescence-activated cell sorting (FACS) -sorted CD4 + CD127 + CD25 low T cells were electroporated with a CRISPR-Cas9 ribonucleoprotein complex (RNP) targeting the constant region of the TCR β chain gene (TRBC), followed by stimulation with anti-CD3/CD28 beads (1:1 ratio). (C) Representative results of flow cytometric analysis of the CD3 expression over time of cells electroporated with or without RNP. Percentages of residual CD3 + population and fold-expansion after 9 days of culture of CD4 + T cells electroporated with or without RNPs targeting TRBC are shown. Results from four independent experiments. (D) A representative example of carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution of a mixed population of CD3 +/− CAR +/− T restimulated with anti-CD3/28 beads. (E) The normalized CFSE mean fluorescence intensity (MFI) ratio for CD3 − mCherry + , CD3 + mCherry − , and CD3 + mCherry + cells was calculated by dividing CFSE MFI of these populations with the MFI of the CD3 − mCherry − cells in the same culture. Two-way ANOVA was used for statistical analysis (bold line set as reference). (F) Percentages of CD3 + and mCherry + cells before and 5 days after restimulation of edited T cells with anti-CD3/CD28 beads. The Unpaired t -test was performed by comparing CD8-TMD and CD28-TMD-containing CARs on D14. For (E,F) , the results shown are a summary of two independent experiments using T cells from five unrelated donors for each construct. *** p < 0.001.
    Anti Human Cd19 Antibody Variant 9, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd19 antibody variant 9/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    anti human cd19 antibody variant 9 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    90
    Immunochina Pharmaceuticals Co Ltd phycoerythrin-labeled antibody that recognized the single chain fragment variant of the cd19 car
    Agarose gel electrophoresis of SC, OC and linear forms of four plasmids. Lane 1, native plasmid DNA of VSVG; lane 2, 7-day treatment at 50 °C for plasmid DNA of VSVG; lane 3, a mixture of native VSVG plasmid DNA and heat-treated VSVG plasmid DNA at ratio of 1:1; lane 4, native plasmid DNA of MDK; lane 5, 7-day treatment at 50 °C for plasmid DNA of MDK; lane 6, a mixture of native MDK plasmid DNA and heat-treated MDK plasmid DNA at ratio of 1:1; lane 7, native plasmid DNA of RSK; lane 8, 7-day treatment at 50 °C for plasmid DNA of RSK; lane 9, a mixture of native RSK plasmid DNA and heat-treated RSK plasmid DNA at ratio of 1:1; lane 10, native plasmid DNA of <t>pLenti6.3/V5-CD19</t> <t>CAR;</t> lane 11, 7-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 12, a mixture of native pLenti6.3/V5-CD19 CAR plasmid DNA and heat-treated pLenti6.3/V5-CD19 CAR plasmid DNA at ratio of 1:1
    Phycoerythrin Labeled Antibody That Recognized The Single Chain Fragment Variant Of The Cd19 Car, supplied by Immunochina Pharmaceuticals Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phycoerythrin-labeled antibody that recognized the single chain fragment variant of the cd19 car/product/Immunochina Pharmaceuticals Co Ltd
    Average 90 stars, based on 1 article reviews
    phycoerythrin-labeled antibody that recognized the single chain fragment variant of the cd19 car - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Novartis cd19 variants
    Agarose gel electrophoresis of SC, OC and linear forms of four plasmids. Lane 1, native plasmid DNA of VSVG; lane 2, 7-day treatment at 50 °C for plasmid DNA of VSVG; lane 3, a mixture of native VSVG plasmid DNA and heat-treated VSVG plasmid DNA at ratio of 1:1; lane 4, native plasmid DNA of MDK; lane 5, 7-day treatment at 50 °C for plasmid DNA of MDK; lane 6, a mixture of native MDK plasmid DNA and heat-treated MDK plasmid DNA at ratio of 1:1; lane 7, native plasmid DNA of RSK; lane 8, 7-day treatment at 50 °C for plasmid DNA of RSK; lane 9, a mixture of native RSK plasmid DNA and heat-treated RSK plasmid DNA at ratio of 1:1; lane 10, native plasmid DNA of <t>pLenti6.3/V5-CD19</t> <t>CAR;</t> lane 11, 7-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 12, a mixture of native pLenti6.3/V5-CD19 CAR plasmid DNA and heat-treated pLenti6.3/V5-CD19 CAR plasmid DNA at ratio of 1:1
    Cd19 Variants, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19 variants/product/Novartis
    Average 90 stars, based on 1 article reviews
    cd19 variants - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    MedImmune llc humanized cd19 antibodies and variants
    Agarose gel electrophoresis of SC, OC and linear forms of four plasmids. Lane 1, native plasmid DNA of VSVG; lane 2, 7-day treatment at 50 °C for plasmid DNA of VSVG; lane 3, a mixture of native VSVG plasmid DNA and heat-treated VSVG plasmid DNA at ratio of 1:1; lane 4, native plasmid DNA of MDK; lane 5, 7-day treatment at 50 °C for plasmid DNA of MDK; lane 6, a mixture of native MDK plasmid DNA and heat-treated MDK plasmid DNA at ratio of 1:1; lane 7, native plasmid DNA of RSK; lane 8, 7-day treatment at 50 °C for plasmid DNA of RSK; lane 9, a mixture of native RSK plasmid DNA and heat-treated RSK plasmid DNA at ratio of 1:1; lane 10, native plasmid DNA of <t>pLenti6.3/V5-CD19</t> <t>CAR;</t> lane 11, 7-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 12, a mixture of native pLenti6.3/V5-CD19 CAR plasmid DNA and heat-treated pLenti6.3/V5-CD19 CAR plasmid DNA at ratio of 1:1
    Humanized Cd19 Antibodies And Variants, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/humanized cd19 antibodies and variants/product/MedImmune llc
    Average 90 stars, based on 1 article reviews
    humanized cd19 antibodies and variants - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    Anti-CD28 stimulation of CD19-chimeric antigen receptors (CAR) T cells is TMD dependent. (A) Designs of five CAR against CD19 bearing a 4-1BB costimulatory domain and differing by their hinge domain (HD) and their transmembrane domain (TMD). (B) Fluorescence-activated cell sorting (FACS) -sorted CD4 + CD127 + CD25 low T cells were electroporated with a CRISPR-Cas9 ribonucleoprotein complex (RNP) targeting the constant region of the TCR β chain gene (TRBC), followed by stimulation with anti-CD3/CD28 beads (1:1 ratio). (C) Representative results of flow cytometric analysis of the CD3 expression over time of cells electroporated with or without RNP. Percentages of residual CD3 + population and fold-expansion after 9 days of culture of CD4 + T cells electroporated with or without RNPs targeting TRBC are shown. Results from four independent experiments. (D) A representative example of carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution of a mixed population of CD3 +/− CAR +/− T restimulated with anti-CD3/28 beads. (E) The normalized CFSE mean fluorescence intensity (MFI) ratio for CD3 − mCherry + , CD3 + mCherry − , and CD3 + mCherry + cells was calculated by dividing CFSE MFI of these populations with the MFI of the CD3 − mCherry − cells in the same culture. Two-way ANOVA was used for statistical analysis (bold line set as reference). (F) Percentages of CD3 + and mCherry + cells before and 5 days after restimulation of edited T cells with anti-CD3/CD28 beads. The Unpaired t -test was performed by comparing CD8-TMD and CD28-TMD-containing CARs on D14. For (E,F) , the results shown are a summary of two independent experiments using T cells from five unrelated donors for each construct. *** p < 0.001.

    Journal: Frontiers in Immunology

    Article Title: The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28

    doi: 10.3389/fimmu.2021.639818

    Figure Lengend Snippet: Anti-CD28 stimulation of CD19-chimeric antigen receptors (CAR) T cells is TMD dependent. (A) Designs of five CAR against CD19 bearing a 4-1BB costimulatory domain and differing by their hinge domain (HD) and their transmembrane domain (TMD). (B) Fluorescence-activated cell sorting (FACS) -sorted CD4 + CD127 + CD25 low T cells were electroporated with a CRISPR-Cas9 ribonucleoprotein complex (RNP) targeting the constant region of the TCR β chain gene (TRBC), followed by stimulation with anti-CD3/CD28 beads (1:1 ratio). (C) Representative results of flow cytometric analysis of the CD3 expression over time of cells electroporated with or without RNP. Percentages of residual CD3 + population and fold-expansion after 9 days of culture of CD4 + T cells electroporated with or without RNPs targeting TRBC are shown. Results from four independent experiments. (D) A representative example of carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution of a mixed population of CD3 +/− CAR +/− T restimulated with anti-CD3/28 beads. (E) The normalized CFSE mean fluorescence intensity (MFI) ratio for CD3 − mCherry + , CD3 + mCherry − , and CD3 + mCherry + cells was calculated by dividing CFSE MFI of these populations with the MFI of the CD3 − mCherry − cells in the same culture. Two-way ANOVA was used for statistical analysis (bold line set as reference). (F) Percentages of CD3 + and mCherry + cells before and 5 days after restimulation of edited T cells with anti-CD3/CD28 beads. The Unpaired t -test was performed by comparing CD8-TMD and CD28-TMD-containing CARs on D14. For (E,F) , the results shown are a summary of two independent experiments using T cells from five unrelated donors for each construct. *** p < 0.001.

    Article Snippet: For generating CD19 − variants of Raji cells, Raji cells (ATCC® CCL-86TM, Manassas, VA) were electroporated (pulse code EH140) with RNP targeting CD19 , and the CD19- negative fraction was purified by FACS after culturing the cells for more than 1 week.

    Techniques: Fluorescence, FACS, CRISPR, Expressing, Construct

    CAR-CD28 heterodimers are B7-unresponsive. (A) A representative example showing CD71 upregulation in CAR T cells containing an IgG 4 -HD/CD28-TMD co-cultured for 48 h with irradiated (4,000 Rad) CD19-wild type or deficient Raji cells with or without CTLA-4 Ig. (B) CD25 + CD71 + T cells were analyzed in low, intermediate (int), or high mCherry-expressing CAR T cells using the gating strategy described in . Data were pooled from four independent experiments using T cells from four to five unrelated donors. The two-way ANOVA was used for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Frontiers in Immunology

    Article Title: The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28

    doi: 10.3389/fimmu.2021.639818

    Figure Lengend Snippet: CAR-CD28 heterodimers are B7-unresponsive. (A) A representative example showing CD71 upregulation in CAR T cells containing an IgG 4 -HD/CD28-TMD co-cultured for 48 h with irradiated (4,000 Rad) CD19-wild type or deficient Raji cells with or without CTLA-4 Ig. (B) CD25 + CD71 + T cells were analyzed in low, intermediate (int), or high mCherry-expressing CAR T cells using the gating strategy described in . Data were pooled from four independent experiments using T cells from four to five unrelated donors. The two-way ANOVA was used for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: For generating CD19 − variants of Raji cells, Raji cells (ATCC® CCL-86TM, Manassas, VA) were electroporated (pulse code EH140) with RNP targeting CD19 , and the CD19- negative fraction was purified by FACS after culturing the cells for more than 1 week.

    Techniques: Cell Culture, Irradiation, Expressing

    CAR-CD28 heterodimers reduce CD28 expression. (A) Editing strategy and homology-directed repair-mediated integration into the TRAC locus of various CD19 CARs using an AAV-6 transduction protocol. (B) The expression of Myc and CD28 in a representative example was analyzed 6 days after editing and the removal of beads. (C) The CD28 MFI ratio was calculated by dividing CD28 MFI of Myc + cells by Myc − cells in the same culture. Pooled data from three to four independent experiments across five unrelated donors are shown. Each dot represents one independent editing condition. The two-way ANOVA was used for statistical analysis. *** p < 0.001.

    Journal: Frontiers in Immunology

    Article Title: The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28

    doi: 10.3389/fimmu.2021.639818

    Figure Lengend Snippet: CAR-CD28 heterodimers reduce CD28 expression. (A) Editing strategy and homology-directed repair-mediated integration into the TRAC locus of various CD19 CARs using an AAV-6 transduction protocol. (B) The expression of Myc and CD28 in a representative example was analyzed 6 days after editing and the removal of beads. (C) The CD28 MFI ratio was calculated by dividing CD28 MFI of Myc + cells by Myc − cells in the same culture. Pooled data from three to four independent experiments across five unrelated donors are shown. Each dot represents one independent editing condition. The two-way ANOVA was used for statistical analysis. *** p < 0.001.

    Article Snippet: For generating CD19 − variants of Raji cells, Raji cells (ATCC® CCL-86TM, Manassas, VA) were electroporated (pulse code EH140) with RNP targeting CD19 , and the CD19- negative fraction was purified by FACS after culturing the cells for more than 1 week.

    Techniques: Expressing, Transduction

    Agarose gel electrophoresis of SC, OC and linear forms of four plasmids. Lane 1, native plasmid DNA of VSVG; lane 2, 7-day treatment at 50 °C for plasmid DNA of VSVG; lane 3, a mixture of native VSVG plasmid DNA and heat-treated VSVG plasmid DNA at ratio of 1:1; lane 4, native plasmid DNA of MDK; lane 5, 7-day treatment at 50 °C for plasmid DNA of MDK; lane 6, a mixture of native MDK plasmid DNA and heat-treated MDK plasmid DNA at ratio of 1:1; lane 7, native plasmid DNA of RSK; lane 8, 7-day treatment at 50 °C for plasmid DNA of RSK; lane 9, a mixture of native RSK plasmid DNA and heat-treated RSK plasmid DNA at ratio of 1:1; lane 10, native plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 11, 7-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 12, a mixture of native pLenti6.3/V5-CD19 CAR plasmid DNA and heat-treated pLenti6.3/V5-CD19 CAR plasmid DNA at ratio of 1:1

    Journal: Cytotechnology

    Article Title: Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA

    doi: 10.1007/s10616-020-00433-4

    Figure Lengend Snippet: Agarose gel electrophoresis of SC, OC and linear forms of four plasmids. Lane 1, native plasmid DNA of VSVG; lane 2, 7-day treatment at 50 °C for plasmid DNA of VSVG; lane 3, a mixture of native VSVG plasmid DNA and heat-treated VSVG plasmid DNA at ratio of 1:1; lane 4, native plasmid DNA of MDK; lane 5, 7-day treatment at 50 °C for plasmid DNA of MDK; lane 6, a mixture of native MDK plasmid DNA and heat-treated MDK plasmid DNA at ratio of 1:1; lane 7, native plasmid DNA of RSK; lane 8, 7-day treatment at 50 °C for plasmid DNA of RSK; lane 9, a mixture of native RSK plasmid DNA and heat-treated RSK plasmid DNA at ratio of 1:1; lane 10, native plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 11, 7-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 12, a mixture of native pLenti6.3/V5-CD19 CAR plasmid DNA and heat-treated pLenti6.3/V5-CD19 CAR plasmid DNA at ratio of 1:1

    Article Snippet: Forty-eight hours post transduction, the CAR expressing cells were stained with a phycoerythrin-labeled antibody that recognized the single chain fragment variant of the CD19 CAR (Immunochina Pharmaceuticals, Beijing, China), and analyzed using fluorescent activated cell sorting assay.

    Techniques: Agarose Gel Electrophoresis, Plasmid Preparation

    Groups with different SC proportion of plasmid DNA

    Journal: Cytotechnology

    Article Title: Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA

    doi: 10.1007/s10616-020-00433-4

    Figure Lengend Snippet: Groups with different SC proportion of plasmid DNA

    Article Snippet: Forty-eight hours post transduction, the CAR expressing cells were stained with a phycoerythrin-labeled antibody that recognized the single chain fragment variant of the CD19 CAR (Immunochina Pharmaceuticals, Beijing, China), and analyzed using fluorescent activated cell sorting assay.

    Techniques: Plasmid Preparation, Concentration Assay

    Agarose gel electrophoresis of SC, OC and linear forms of four plasmids after heat or enzyme treatment. Lane 1, native plasmid DNA of RSK; lane 2, 7-day treatment at 50 °C for plasmid DNA of RSK; lane 3, 10-day treatment at 50 °C for plasmid DNA of RSK; lane 4, RSK plasmid DNA was digested with Xho I; lane 5, native plasmid DNA of VSVG; lane 6, 7-day treatment at 50 °C for plasmid DNA of VSVG; lane 7, 10-day treatment at 50 °C for plasmid DNA of VSVG; lane 8, VSVG plasmid DNA was digested with Hand III; lane 9, native plasmid DNA of MDK; lane 10, 7-day treatment at 50 °C for plasmid DNA of MDK; lane 11, 10-day treatment at 50 °C for plasmid DNA of MDK; lane 12, MDK plasmid DNA was digested with Mun I; lane 13, native plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 14, 7-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 15, 10-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 16, pLenti6.3/V5-CD19 CAR plasmid DNA digested with Sal I

    Journal: Cytotechnology

    Article Title: Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA

    doi: 10.1007/s10616-020-00433-4

    Figure Lengend Snippet: Agarose gel electrophoresis of SC, OC and linear forms of four plasmids after heat or enzyme treatment. Lane 1, native plasmid DNA of RSK; lane 2, 7-day treatment at 50 °C for plasmid DNA of RSK; lane 3, 10-day treatment at 50 °C for plasmid DNA of RSK; lane 4, RSK plasmid DNA was digested with Xho I; lane 5, native plasmid DNA of VSVG; lane 6, 7-day treatment at 50 °C for plasmid DNA of VSVG; lane 7, 10-day treatment at 50 °C for plasmid DNA of VSVG; lane 8, VSVG plasmid DNA was digested with Hand III; lane 9, native plasmid DNA of MDK; lane 10, 7-day treatment at 50 °C for plasmid DNA of MDK; lane 11, 10-day treatment at 50 °C for plasmid DNA of MDK; lane 12, MDK plasmid DNA was digested with Mun I; lane 13, native plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 14, 7-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 15, 10-day treatment at 50 °C for plasmid DNA of pLenti6.3/V5-CD19 CAR; lane 16, pLenti6.3/V5-CD19 CAR plasmid DNA digested with Sal I

    Article Snippet: Forty-eight hours post transduction, the CAR expressing cells were stained with a phycoerythrin-labeled antibody that recognized the single chain fragment variant of the CD19 CAR (Immunochina Pharmaceuticals, Beijing, China), and analyzed using fluorescent activated cell sorting assay.

    Techniques: Agarose Gel Electrophoresis, Plasmid Preparation

    The information of four plasmids for lentivirus packaging

    Journal: Cytotechnology

    Article Title: Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA

    doi: 10.1007/s10616-020-00433-4

    Figure Lengend Snippet: The information of four plasmids for lentivirus packaging

    Article Snippet: Forty-eight hours post transduction, the CAR expressing cells were stained with a phycoerythrin-labeled antibody that recognized the single chain fragment variant of the CD19 CAR (Immunochina Pharmaceuticals, Beijing, China), and analyzed using fluorescent activated cell sorting assay.

    Techniques: Plasmid Preparation